Arteris, Inc. (NASDAQ:AIP - Get Free Report) saw unusually large options trading activity on Tuesday. Traders purchased 15,629 call options on the company. This is an increase of 8,440% compared to the average daily volume of 183 call options.
Analysts Set New Price Targets
Several brokerages have recently weighed in on AIP. Northland Securities lifted their price target on shares of Arteris from $14.00 to $16.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 19th. Rosenblatt Securities restated a "buy" rating and issued a $14.00 target price on shares of Arteris in a report on Wednesday, May 21st.
Check Out Our Latest Stock Analysis on Arteris
Arteris Stock Up 12.5%
Shares of AIP traded up $1.03 during mid-day trading on Tuesday, hitting $9.25. The company's stock had a trading volume of 1,621,775 shares, compared to its average volume of 215,408. The company's 50-day moving average is $7.13 and its 200-day moving average is $8.59. Arteris has a 52-week low of $5.46 and a 52-week high of $12.64. The firm has a market capitalization of $388.13 million, a price-to-earnings ratio of -10.56 and a beta of 1.37. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30.
Insider Transactions at Arteris
In other news, COO Laurent R. Moll sold 4,703 shares of the stock in a transaction that occurred on Wednesday, April 2nd. The shares were sold at an average price of $7.12, for a total transaction of $33,485.36. Following the sale, the chief operating officer now owns 482,833 shares in the company, valued at $3,437,770.96. This represents a 0.96% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Nicholas B. Hawkins sold 11,000 shares of the stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $7.54, for a total transaction of $82,940.00. Following the sale, the chief financial officer now owns 165,596 shares in the company, valued at approximately $1,248,593.84. The trade was a 6.23% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,895 shares of company stock valued at $365,310. Insiders own 29.10% of the company's stock.
Institutional Investors Weigh In On Arteris
Hedge funds have recently modified their holdings of the business. G2 Investment Partners Management LLC purchased a new stake in Arteris during the fourth quarter valued at approximately $2,799,000. Acadian Asset Management LLC lifted its position in Arteris by 40.6% during the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after acquiring an additional 260,277 shares during the last quarter. AQR Capital Management LLC purchased a new stake in Arteris during the first quarter valued at approximately $1,621,000. Federated Hermes Inc. lifted its position in Arteris by 97.2% during the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock valued at $2,260,000 after acquiring an additional 161,241 shares during the last quarter. Finally, Next Century Growth Investors LLC lifted its position in Arteris by 46.4% during the first quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock valued at $2,817,000 after acquiring an additional 129,143 shares during the last quarter. Hedge funds and other institutional investors own 64.36% of the company's stock.
About Arteris
(
Get Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.